Get informed when a big investor buys or sells
+ FollowNovember 4, 2026 - AI Summary
Overvalued by 50.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $31.62 Billion |
|---|---|
| Enterprise Value | $41.93 Billion |
| Annual dividend | $1.22 |
| Dividend yield | 1.96% |
| Earnings per Share | $2.25 |
| Beta | 0.83 |
| Outstanding Shares | 559,722,000 |
| P/E Ratio | 19.15 |
|---|---|
| PEG | 114.5 |
| Price to Sales | 1.35 |
| Price to Book Ratio | 1.53 |
| Enterprise Value to Revenue | 1.76 |
| Enterprise Value to EBIT | 17.24 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 0.59 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Fresenius SE & Co. KGaA operates as a diverse healthcare enterprise, supplying a comprehensive array of products and services primarily focused on dialysis, hospital management, and outpatient medical care. Its activities are structured ...